• 802/2, Sampa, Nr. Jaliyamath Railway Station, Dehgam, Gandhinagar

Follow Us:

Products

  |  Products

Product Portfolio

Product
Dosage
Form/Strength
Indication
Status

Alimentry tract and Metabolism

Vildagliptin tablet
Dosage / Strength tablet - 500 MG
Indication Type 2 Diabetes Mellitus
Status Under Development
Metformin IR/SR tablet
Dosage / Strength tablet - 500/850/1000 mg
Indication Type 2 Diabetes Mellitus
Status Developed
Metformin (SR) & Glimepride tablet
Dosage / Strength tablet - 500 mg + 1 mg
Indication Type 2 Diabetes Mellitus
Status Developed
Metformin (SR) & Glimepride tablet
Dosage / Strength tablet - 500 mg + 2 mg
Indication Type 2 Diabetes Mellitus
Status Developed
Metformin (SR) & Glimepride tablet
Dosage / Strength tablet - 1000 mg + 1 mg
Indication Type 2 Diabetes Mellitus
Status Developed
Metformin (SR) & Glimepride tablet
Dosage / Strength tablet - 1000 mg + 2 mg
Indication Type 2 Diabetes Mellitus
Status Developed
Dapaglifozolin
Dosage / Strength tablet - 10 mg
Indication Type 2 Diabetes Mellitus, Heart Failure, CKD
Status Developed
Dapaglifozin + Metmorfn HCL
Dosage / Strength tablet - 10 mg + 500 mg
Indication Type 2 Diabetes Mellitus
Status Developed
Empaglifozolin (EU Support)
Dosage / Strength tablet - 10/25 mg
Indication Type 2 Diabetes Mellitus, Heart Failure, CKD
Status Under Development
Sitagliptine (EU Support)
Dosage / Strength tablet - 50 mg
Indication Type 2 Diabetes Mellitus
Status Developed
Sitagliptine + Metformine
Dosage / Strength tablet - 50+500/50+1000 mg
Indication Type 2 Diabetes Mellitus
Status Developed
Canaglifozolin
Dosage / Strength tablet - 300 mg
Indication Type 2 Diabetes Mellitus
Status Developed
Glibenclamide
Dosage / Strength tablet - 2.5/5/10 mg
Indication Type 2 Diabetes Mellitus
Status Developed

Antiinfectives for systemic use

Azithromycin
Dosage / Strength tablet - 250, 500 mg
Indication Bacterial Infections
Status Developed
Ciprofloxacin
Dosage / Strength tablet - 250, 500 mg
Indication Bacterial Infections
Status Developed
Ciprofoxacin + Tinidazole
Dosage / Strength tablet - 500 mg + 600 mg
Indication Mixed Bacterial & Protozoal Infections
Status Developed
Ofloxacin + Ornidazole
Dosage / Strength tablet - 200+500mg
Indication Gastrointestinal & Mixed Infections
Status Developed
Livofloxacin
Dosage / Strength tablet - 250, 500mg
Indication Bacterial Infections
Status Developed

Blood and Anticoagulants

Rivaroxaban
Dosage / Strength tablet - 5/10/15/20 mg
Indication Prevention & Treatment of Thromboembolism
Status Developed
Aspirin
Dosage / Strength tablet - 75/150 mg
Indication Antiplatelet Therapy, Pain, Fever
Status Developed
Aspirin + Clopidogrel
Dosage / Strength tablet - 75+75 mg
Indication Prevention of Cardiovascular Events
Status Developed
Aspirin + Clopidogrel + Rosuvastatin
Dosage / Strength tablet - 75+75+20 mg
Indication Cardiovascular Risk Reduction
Status Developed
Atorvastatin
Dosage / Strength tablet - 10/20/40/80 mg
Indication Hyperlipidemia
Status Developed
Atorvastatin + Fenofibrate
Dosage / Strength tablet - 100 mg + 160 mg
Indication Mixed Dyslipidemia
Status Developed
Rosuvastatin
Dosage / Strength tablet - 10/20/40 mg
Indication Hyperlipidemia
Status Developed
Rosuvastatin + Fenofibrate
Dosage / Strength tablet - 20 mg + 160 mg
Indication Mixed Dyslipidemia
Status Developed
Apixaban
Dosage / Strength tablet - 2.5/5 mg
Indication Prevention & Treatment of Thromboembolism
Status Developed
Ticagrelor
Dosage / Strength tablet - 60/90 mg
Indication Antiplatelet
Status Developed
Dabigatran
Dosage / Strength capsule - 75/150 mg
Indication Anticoagulant
Status Developed

Cardiovascular System

Amlodipine
Dosage / Strength tablet - 2.5/5/10 mg
Indication Hypertension, Angina
Status Developed
Metoprolol Succinate extended release
Dosage / Strength tablet - 12.5/25/50/100 mg
Indication Hypertension, Heart Failure, Angina
Status Developed
Valsartan
Dosage / Strength tablet - 80 mg
Indication Hypertension, Heart Failure
Status Developed
Valsartan + Amlodipine
Dosage / Strength tablet - 80 mg + 5 mg
Indication Hypertension
Status Developed
Telmisartan
Dosage / Strength tablet - 40 mg
Indication Hypertension
Status Developed
Telmisartan + Amlodipine
Dosage / Strength tablet - 40 mg + 5 mg
Indication Hypertension
Status Developed
Telmisartan + Hydrochlorothiazide
Dosage / Strength tablet - 40 mg + 12.5 mg
Indication Hypertension
Status Developed
Telmisartan + Amlodipine + Hydrochlorothiazide
Dosage / Strength tablet - 40 mg + 5 mg + 12.5 mg
Indication Hypertension
Status Developed
Olmesartan + Amlodipine + Hydrochlorothiazide
Dosage / Strength tablet - 20 mg + 5 mg + 12.5 mg
Indication Hypertension
Status Developed
Hydrochlorothiazide
Dosage / Strength tablet - 25 mg
Indication Hypertension, Edema
Status Developed
Propranolol Hydrochloride ER
Dosage / Strength Capsules - 60/80/120/160 mg
Indication Hypertension
Status Under Development
Atenolol
Dosage / Strength tablet - 25/50 mg
Indication Hypertension
Status Developed
Losartan Potassium
Dosage / Strength tablet - 25/50/100 mg
Indication Hypertension
Status Developed
Irbesartan
Dosage / Strength tablet - 75/150/300 mg
Indication Hypertension
Status Developed
Ivabradine
Dosage / Strength tablet - 2.5/5/7.5 mg
Indication Heart Failure, Angina
Status Developed
Nifedipine
Dosage / Strength tablet - 10/20/30/60/90 mg
Indication Hypertension, Angina
Status Developed
Cilnidipine HCL
Dosage / Strength tablet - 5/10 mg
Indication Hypertension
Status Developed

Musculo-skeletal system

Baclofen
Dosage / Strength tablet - 10 mg
Indication Skeletal Muscle Relaxant
Status Developed
Tolperisone HCL
Dosage / Strength tablet - 150 mg
Indication Skeletal Muscle Relaxant
Status Developed
Tizanidine
Dosage / Strength tablet - 2/4 mg
Indication Skeletal Muscle Relaxant
Status Developed

Pain Management

Aceclofenac
Dosage / Strength tablet - 100 mg
Indication Pain, Inflammation
Status Developed
Diclofanac Sodium/Potassium
Dosage / Strength tablet - 50 mg
Indication Pain
Status Developed
Diclofanac Potassium GR
Dosage / Strength capsule - 100 mg
Indication Pain
Status Developed
Aceclofenac + Paracetamol
Dosage / Strength tablet - 100 mg + 325 mg
Indication Pain, Inflammation
Status Developed
Ibuprofen
Dosage / Strength tablet - 400 mg
Indication Pain, Fever, Inflammation
Status Developed
Paracetamol
Dosage / Strength tablet - 500/650 mg
Indication Pain, Fever, Inflammation
Status Developed
Meloxicam
Dosage / Strength tablet/capsule - 7.5/15 mg tablet, 5/10 mg capsule
Indication Arthritis & Pain
Status Developed
Celecoxib
Dosage / Strength capsule - 50/100/200/400 mg
Indication Arthritis & Pain
Status Developed

Nervous system

Gabapentin
Dosage / Strength tablet - 100/300/400 mg
Indication Neuropathic Pain, Epilepsy
Status Developed
Pregabalin
Dosage / Strength capsule - 5/50/75/100/150/200/225/300 mg
Indication Neuropathic Pain, Fibromyalgia
Status Developed
Pregabalin + Methylcobalamin
Dosage / Strength tablet - 75 mg + 750 mcg
Indication Neuropathic Pain, Fibromyalgia
Status Developed
Pregabaline + Duloxetine
Dosage / Strength capsule - 50+20 mg
Indication Major depressive disorder and anxiety
Status Developed
Fluoxetine
Dosage / Strength tablet - 10/20 mg
Indication Major depressive disorder and anxiety
Status Developed
Sertraline
Dosage / Strength tablet - 25/50/100 mg
Indication Major depressive disorder and anxiety
Status Developed
Escitalopram
Dosage / Strength tablet - 5/10/15/20 mg
Indication Major depressive disorder and anxiety
Status Developed
Citalopram
Dosage / Strength tablet - 10/20/40 mg
Indication Major depressive disorder and anxiety
Status Developed
Venlafaxine
Dosage / Strength tablet - 37.5/75/100 mg
Indication Major depressive disorder and anxiety
Status Developed
Duloxetine
Dosage / Strength tablet - 20/30/40 mg
Indication Major depressive disorder and anxiety
Status Developed
Bupropion
Dosage / Strength tablet - 75/100/150/200 mg
Indication Major depressive disorder and anxiety
Status Developed
Mirtazapine
Dosage / Strength tablet - 7.5/15/30/45 mg
Indication Major depressive disorder and anxiety
Status Developed
Buspirone
Dosage / Strength tablet - 5/7.5/10/15/30 mg
Indication Manage anxiety, panic attacks and related disorders
Status Developed
Pregabalin + Nortryptaline
Dosage / Strength tablet - 50+10mg, 75+10mg, 75+10mg, 150+10mg
Indication Manage anxiety, panic attacks and related disorders
Status Developed
Methylphenidate
Dosage / Strength tablet - 5/10/20 mg
Indication Increase focus and control impulses
Status Developed
Dexmethylphenidate
Dosage / Strength tablet/capsule - 2.5/5/10 mg tablet, 5/10/15/20/25/30/35/40 mg capsule
Indication Increase focus and control impulses
Status Developed
Atomoxetine
Dosage / Strength capsule - 10/18/25/40/60/80/100 mg
Indication Increase focus and control impulses
Status Developed
Guanfacine
Dosage / Strength tablet - 1/2 mg
Indication Increase focus and control impulses
Status Developed
Quetiapine
Dosage / Strength tablet - 25/50/100/150/200/300/400 mg
Indication Psychosis, schizophrenia, and bipolar disorder
Status Developed
Olanzapine
Dosage / Strength tablet - 2.5/5/10/15 mg
Indication Psychosis, schizophrenia, and bipolar disorder
Status Developed
Aripiprazole
Dosage / Strength tablet - 2/5/10/15/20/30 mg
Indication Psychosis, schizophrenia, and bipolar disorder
Status Developed
Risperidone
Dosage / Strength tablet - 0.25/0.5/1/2/3/4/6 mg
Indication Psychosis, schizophrenia, and bipolar disorder
Status Developed
Lurasidone
Dosage / Strength tablet - 20/40/80/120 mg
Indication Psychosis, schizophrenia, and bipolar disorder
Status Developed
Lamotrigine
Dosage / Strength tablet - IR 25/100/150/200mg, Dispersible 2/5/25/100mg, ODT 25/50/100/200mg, ER 25/50/100/200/250/300mg
Indication Treat mood swings associated with bipolar disorder
Status Developed

Derma Care

Itraconazole
Dosage / Strength capsule - 100/200 mg
Indication Fungal Infections
Status Developed
Fluconazole
Dosage / Strength capsule - 150/200 mg
Indication Fungal Infections
Status Developed
Clindamycin Hydrochloride
Dosage / Strength capsule - 300 mg
Indication Bacterial Infections
Status Developed
Metronidazole
Dosage / Strength tablet - 250/500 mg
Indication Anaerobic Bacterial & Protozoal Infections
Status Developed
Posaconazole DR
Dosage / Strength tablet - 100 mg
Indication Fungal Infections
Status Under Development
Bilastine
Dosage / Strength tablet - 10/20 mg
Indication Anti-Allergy
Status Developed
Fexofenadine
Dosage / Strength tablet/capsule - 30/60/120 mg
Indication Anti-Allergy
Status Developed

Respiratory Medication

Levocetirizine
Dosage / Strength tablet - 5 mg
Indication Allergic Rhinitis, Urticaria
Status Developed
Levocetirizine + Montelukast Sodium
Dosage / Strength tablet - 5 mg + 10 mg
Indication Allergic Rhinitis, Urticaria
Status Developed
Sulbutamol HCL
Dosage / Strength tablet - 2/4 mg
Indication Allergic Rhinitis, Urticaria
Status Developed
Acebrophylline
Dosage / Strength tablet - 100/200 mg
Indication Bronchodilator
Status Developed
Theophylline
Dosage / Strength tablet - 300/600 mg
Indication Bronchodilator
Status Developed

Anticonvulsant/Anti Epileptic

Sodium Valproate tablet
Dosage / Strength tablet - 500 mg
Indication Epilepsy, Bipolar Disorder, Migraine Prevention
Status Developed
Levitracetam tablet
Dosage / Strength tablet - 250/500 mg
Indication Epilepsy
Status Developed

Anti-Retro viral Medication

Aciclovir tablet
Dosage / Strength tablet - 400 mg
Indication Herpes Virus Infections
Status Developed
Albendazole tablet
Dosage / Strength tablet - 400 mg
Indication Helminth (Worm) Infections
Status Developed
Valcyclovir tablet
Dosage / Strength tablet - 500/1000 mg
Indication Herpes Virus Infections
Status Under Development
Oseltamivir capsule
Dosage / Strength capsule - 75 mg
Indication Influenza A & B
Status Under Development
Raltegravir tablet
Dosage / Strength tablet - 400 mg
Indication HIV Infection
Status Under Development

Anti-Depressant Medication

Sertraline tablet
Dosage / Strength tablet - 25/50/100 mg
Indication Depression, Anxiety Disorders
Status Developed
Buproprion Extended Release + Dexmethrophen Hydrobromide
Dosage / Strength tablet - 105 mg + 45 mg
Indication Depression, Anxiety Disorders
Status Under Development
Duloxein Delayed Release
Dosage / Strength capsule - 20/30/40/60 mg
Indication Depression, Anxiety Disorders
Status Under Development

Antipsychotic Medication

Risperidone
Dosage / Strength tablet - 0.5/1/2 mg
Indication Schizophrenia, Bipolar Disorder
Status Developed
Paliperidone Extended Release
Dosage / Strength tablet - 1.5, 3.0, 6.0, 9.0 mg
Indication Schizophrenia, Bipolar Disorder
Status Under Development

Gastro intestinal system

Dexlansoprazole Delayed Release
Dosage / Strength capsule - 30/60 mg
Indication Gastroesophageal Reflux Disease (GERD)
Status Developed
Vonoprazan fumarate
Dosage / Strength tablet - 10/20 mg
Indication Gastroesophageal Reflux Disease (GERD)
Status Under Development

Urinary Antispasmodic

Mirabegron ER Tablets
Dosage / Strength tablet - 25/50 mg
Indication Overactive bladder (OAB)
Status Under Development

Product Portfolio Externals

Product
Status

External Preparations

Adapalene 0.1% + Clindamycin 1%
Status Developed
Luliconazole 1%
Status Developed
Clobetasol 0.05%, Miconazole 2% & neomycin 0.5%
Status Developed
Mupirocin 2%
Status Developed
Adapalene 0.1%
Status Developed
Mometasone Furoate
Status Developed
Fusidic Acid 2.0%
Status Developed
Acyclovir 5%
Status Developed
Benzoyl Peroxide 2.5%
Status Developed
Fusidic Acid 2% and Hydrocortisone Acetate 1%
Status Developed
Tacrolimus Ointment 0.1%
Status Developed
Minoxidil Topical Solution 5/10%
Status Developed
Ketoconazole 2%
Status Developed
Dexpanthenol Ointment 5%
Status Developed
Tretinoin 0.1%
Status Developed
Glycolic acid 6/12%
Status Developed
Clindamycin 1%
Status Developed
Amorolfine 0.25%
Status Developed
Terbinafine HCL 1%
Status Developed

Musculoskeletal system

Diclofenac Diethylamine 1.16%, Linseed Oil 3%, Methyl Salicylate 10% & Menthol 10% Gel
Status Developed

Antiseptic

Povidone-Iodine 5% Ointment
Status Developed